Demonstrations available at booth 111 in EXPO X1
STOCKHOLM – Feb. 20, 2019 – At this year’s European Congress of Radiology (ECR) in Vienna, ContextVision will show Altumira, its latest image enhancement platform.
With deep learning technology integrated, Altumira is specially designed to meet the demanding needs of digital radiography for both dynamic and static X-ray. Altumira addresses significant challenges regarding robustness, brightness stabilization and high image quality that have been difficult to solve before, including:
- Varying exposure conditions between patients
- A wide variety of image characteristics and requirements for all types of anatomies
- Varying dose and intensity levels, as well as organs and collimators in motion in dynamic sequences
“Deep learning is a natural fit for us and represents tremendously enhanced capabilities,” said Fredrik Palm, Vice President of OEM Business, ContextVision. “We are relentless in our pursuit of research and product development to continuously spearhead the medical image processing and image analysis field with valuable products.”
Based on more than 35 years of industry-leading image processing expertise, ContextVision’s latest cutting-edge technology provides robust excellent image quality that results in faster throughput and gives clinicians higher diagnostic confidence. “With our next-generation image enhancement, we’re bringing great value and confidence to both manufacturers and radiologists, providing them the highest image quality in every exam,” said Ann-Sofi Hoff, Product Portfolio Manager, ContextVision.
Altumira is designed for all digital radiography systems, from plain X-ray to the most advanced angiography systems. This new product expands ContextVision’s product portfolio of state-of-the-art image enhancement for 2D/3D/4D ultrasound, MRI, X-ray and mammography.
At ECR, the full suite of industry-leading image enhancement products for ultrasound will be showcased. ContextVision’s products deliver unsurpassed image quality for all types of ultrasound systems from handheld devices to the most advanced 3D/4D applications.
Demonstrations of Altumira, as well as ContextVision’s other innovative solutions, will occur at booth #111 in EXPO X1 at ECR from Feb. 28 – March 3. To schedule a presentation, please visit www.contextvision.com/ecr2019.
ContextVision is a medical technology company specializing in image analysis and artificial intelligence. Its cutting-edge technology continues to create valuable insights through intelligent imaging. The company’s product portfolio offers state-of-the-art image enhancement software for 2D/3D/4D ultrasound, MRI, radiography and mammography. The products are used by leading equipment manufacturers worldwide to produce unsurpassed image quality. All over the world, clinicians rely on ContextVision’s technology to get the answers they need from medical imaging. ContextVision is based in Sweden and listed on the Oslo Stock Exchange under the ticker COV. For more information, please visit www.contextvision.com.